These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 20096226)

  • 1. Long-term laryngeal allograft survival using low-dose everolimus.
    Lott DG; Dan O; Lu L; Strome M
    Otolaryngol Head Neck Surg; 2010 Jan; 142(1):72-8. PubMed ID: 20096226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decoy NF-kappaB fortified immature dendritic cells maintain laryngeal allograft integrity and provide enhancement of regulatory T cells.
    Lott DG; Dan O; Lu L; Strome M
    Laryngoscope; 2010 Jan; 120(1):44-52. PubMed ID: 19877191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laryngeal transplantation in the setting of cancer: a rat model.
    Shipchandler TZ; Lorenz RR; Lee WT; Teker AM; Dan O; Strome M
    Laryngoscope; 2008 Dec; 118(12):2166-71. PubMed ID: 18948827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressive TOR kinase inhibitor everolimus (RAD) suppresses growth of cells derived from posttransplant lymphoproliferative disorder at allograft-protecting doses.
    Majewski M; Korecka M; Joergensen J; Fields L; Kossev P; Schuler W; Shaw L; Wasik MA
    Transplantation; 2003 May; 75(10):1710-7. PubMed ID: 12777861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction with T-cell receptor antibody leads to long-term laryngeal allograft function.
    Knott PD; Dan O; Strome M
    Am J Otolaryngol; 2008; 29(6):398-402. PubMed ID: 19144301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
    Cai Y; Tang XD; Zhou PJ
    Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolongation of corneal allograft survival by topical application of everolimus in experimental keratoplasty.
    Li XQ; Buch G; Otasevic L; Schlickeiser S; Bertelmann E; Pleyer U
    Ophthalmic Res; 2008 Oct; 40(6):309-14. PubMed ID: 18688173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic insights into achievement of cardiac allograft long-term survival by treatment with immature dendritic cells and sub-dose sirolimus.
    Tao R; Wang L; Chen CH; Wang SH; Demarco RA; Lotze MT; Thai NL; Fung JJ; Lu L; Qian S
    J Heart Lung Transplant; 2006 Mar; 25(3):310-9. PubMed ID: 16507425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined therapy of CD4(+)CD25(+) regulatory T cells with low-dose sirolimus, but not calcineurin inhibitors, preserves suppressive function of regulatory T cells and prolongs allograft survival in mice.
    Ma A; Qi S; Wang Z; Massicotte E; Dupuis M; Daloze P; Chen H
    Int Immunopharmacol; 2009 May; 9(5):553-63. PubMed ID: 19539558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolongation of cardiac allograft survival by rapamycin and the invariant natural killer T cell glycolipid agonist OCH.
    Haeryfar SM; Lan Z; Leon-Ponte M; Duffy KR; Ge W; Liu W; Mele T; Garcia B; Wang H
    Transplantation; 2008 Aug; 86(3):460-8. PubMed ID: 18698251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new mouse laryngeal transplantation rejection grading system.
    Lott DG; Shipchandler TZ; Dan O; Lorenz RR; Strome M
    Laryngoscope; 2010 Jan; 120(1):39-43. PubMed ID: 19877187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term limb allograft survival using a short course of anti-CD45RB monoclonal antibody, LF 15-0195, and rapamycin in a mouse model.
    Zhong T; Liu Y; Jiang J; Wang H; Temple CL; Sun H; Garcia B; Zhong R; Ross DC
    Transplantation; 2007 Dec; 84(12):1636-43. PubMed ID: 18165776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alloantigen-pulsed host dendritic cells induce T-cell regulation and prolong allograft survival in a rat model of hindlimb allotransplantation.
    Kuo YR; Huang CW; Goto S; Wang CT; Hsu LW; Lin YC; Yang KD; Chen CL; Lee WP
    J Surg Res; 2009 May; 153(2):317-25. PubMed ID: 19101689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis.
    Bemelman FJ; de Maar EF; Press RR; van Kan HJ; ten Berge IJ; Homan van der Heide JJ; de Fijter HW
    Transplantation; 2009 Aug; 88(3):421-8. PubMed ID: 19667948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporine reduction in the presence of everolimus: 3-month data from a Canadian pilot study of maintenance cardiac allograft recipients.
    Ross H; Pflugfelder P; Haddad H; Cantarovich M; White M; Ignaszewski A; Howlett J; Vaillancourt M; Dorent R; Burton JR;
    J Heart Lung Transplant; 2008 Feb; 27(2):197-202. PubMed ID: 18267227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulsed immunosuppression with everolimus and anti-alphabeta T-cell receptor: laryngeal allograft preservation at six months.
    Khariwala SS; Knott PD; Dan O; Klimczak A; Siemionow M; Strome M
    Ann Otol Rhinol Laryngol; 2006 Jan; 115(1):74-80. PubMed ID: 16466103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of delayed graft function and wound healing complications after deceased-donor kidney transplantation is not affected by de novo everolimus.
    Albano L; Berthoux F; Moal MC; Rostaing L; Legendre C; Genin R; Toupance O; Moulin B; Merville P; Rerolle JP; Bayle F; Westeel PF; Glotz D; Kossari N; Lefrançois N; Charpentier B; Blanc AS; Di Giambattista F; Dantal J;
    Transplantation; 2009 Jul; 88(1):69-76. PubMed ID: 19584683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ten-month laryngeal allograft survival with use of pulsed everolimus and anti-alphabeta T-cell receptor antibody immunosuppression.
    Lott DG; Russell JO; Khariwala SS; Dan O; Strome M
    Ann Otol Rhinol Laryngol; 2011 Feb; 120(2):131-6. PubMed ID: 21391426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor bone marrow in laryngeal transplantation: results of a rat study.
    Khariwala SS; Dan O; Lorenz RR; Klimczak A; Siemionow M; Strome M
    Am J Otolaryngol; 2008; 29(4):242-9. PubMed ID: 18598835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of intestinal allograft rejection by FTY720 and costimulation blockade.
    Yan S; Rodriguez-Barbosa JI; Pabst O; Beckmann JH; Brinkmann V; Förster R; Hoffmann MW
    Transplant Proc; 2005; 37(1):114-5. PubMed ID: 15808565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.